GMS

GMS Takes Tops Spots in HRO Baker's Dozen Survey

Retrieved on: 
Monday, April 8, 2024
Workforce, HRO, GMS, Baker

SCOTTSDALE, Ariz., April 8, 2024 /PRNewswire/ -- Global Mobility Solutions (GMS), the top provider of corporate relocation services and technology, is excited to announce that we have achieved high rankings on HRO Today's 2023 Baker's Dozen survey, showcasing our commitment to customer satisfaction.

Key Points: 
  • SCOTTSDALE, Ariz., April 8, 2024 /PRNewswire/ -- Global Mobility Solutions (GMS), the top provider of corporate relocation services and technology, is excited to announce that we have achieved high rankings on HRO Today's 2023 Baker's Dozen survey, showcasing our commitment to customer satisfaction.
  • In the industry survey, GMS ranked No.
  • "We appreciate our fantastic customers for trusting GMS and allowing us to provide them with top-notch employee relocation services."
  • The Baker's Dozen rankings by HRO Today are highly regarded as the top measure in the field of relocation.

Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million

Retrieved on: 
Monday, March 18, 2024
Retina, GMS, Sale, Visium Asset Management, Bevacizumab, Schonfeld Strategic Advisors, Bank of America, Therapy, Security (finance)

ISELIN, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases in the US and the EU, today announced that it has closed its previously announced private placement, for upfront gross proceeds of approximately $60 million from the issuance and sale of shares of the Company’s common stock and accompanying warrants, before deducting placement agent fees and offering expenses.

Key Points: 
  • ISELIN, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases in the US and the EU, today announced that it has closed its previously announced private placement, for upfront gross proceeds of approximately $60 million from the issuance and sale of shares of the Company’s common stock and accompanying warrants, before deducting placement agent fees and offering expenses.
  • Outlook Therapeutics has the potential to receive additional gross proceeds of up to $99 million upon the full cash exercise of the warrants issued in the private placement, before deducting placement agent fees and offering expenses.
  • The private placement was led by Great Point Partners, LLC, with participation from existing investor GMS Ventures as well as new investors Altium Capital, Armistice Capital, Caligan Partners LP, Schonfeld Strategic Advisors, Sphera Healthcare, Velan Capital, Woodline Partners LP, and an undisclosed life sciences dedicated investor.
  • BofA Securities and BTIG acted as co-placement agents in connection with the financing.

7th Annual Digi-Tech Pharma & AI Conference: Registration Now Open - London, United Kingdom - May 28-29, 2024 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 26, 2024
Health Technology, Pharmaceutical, Health, Genomics, Informatics, GMS, Conference, Data science, Medication, Clinical, Drug discovery, Intelligence, Partnership, Internet of things, Blockchain, Value, Artificial intelligence, Science, AI, Digital health, Deep learning, Medicine, Pleasure, Cloud computing, Head, Machine learning, Data management, VPS, Virtual reality, Fine chemical

The "Digi-Tech Pharma & AI 2024" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Digi-Tech Pharma & AI 2024" conference has been added to ResearchAndMarkets.com's offering.
  • The 7th Annual Digi-Tech Pharma & AI conference, a premier Pharmaceutical Technology Conference, brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare industry.
  • Meet the decision makers, benchmark and learn from real-life use cases to drive organizational change and to understand the new cutting-edge technologies and practical solutions.
  • It gives us a great pleasure in welcoming you to our whole new pharmaceutical technology conference 7th Annual Digi-Tech Pharma & AI 2024.

Global Ship Recycling Market: A Comprehensive Overview by BCC Research

Retrieved on: 
Tuesday, April 2, 2024
GMS, Growth, Steel, Recycling, Copper, Metal, Ship, Statistics, Period, Investment, Compound annual growth rate, BCC, Aluminium

BOSTON, April 2, 2024 /PRNewswire/ -- In the world of ship recycling, India and Bangladesh are major players, accounting for about 80% of the global market. This industry demands significant infrastructure and labor, but investments like Wreckdock's facility and innovations like GMS's digital platform are set to drive its development further.

Key Points: 
  • Global Ship Recycling Market Projected to Reach $11.5 Billion by 2028, BCC Research Study Forecasted Compound Annual Growth Rate of 3.7% for the Period of 2023-2028 Indicates Gradual Market Expansion.
  • "According to the latest BCC Research study, the demand for Global Ship Recycling Market is estimated to reach $11.5 billion by 2028, at a compound annual growth rate (CAGR) of 3.7% for the forecast period 2023-2028."
  • This report offers a comprehensive examination of the ship recycling industry, exploring its current status, prospects, and the evolving landscape shaped by governmental initiatives and technological advancements.
  • India emerges as a dominant player in the global ship recycling market, commanding over 40% of the industry share.

Register Now for the 7th Annual Digi-Tech Pharma & AI Conference: London, United Kingdom - May 28-29, 2024

Retrieved on: 
Friday, March 15, 2024
Genomics, Informatics, GMS, Conference, Data science, Medication, Clinical, Drug discovery, Intelligence, Partnership, Internet of things, Blockchain, Value, Artificial intelligence, Science, AI, Digital health, Deep learning, Medicine, Pleasure, Cloud computing, Head, Machine learning, Data management, VPS, Virtual reality, Fine chemical

DUBLIN, March 15, 2024 /PRNewswire/ -- The "Digi-Tech Pharma & AI 2024" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 15, 2024 /PRNewswire/ -- The "Digi-Tech Pharma & AI 2024" conference has been added to ResearchAndMarkets.com's offering.
  • The 7th Annual Digi-Tech Pharma & AI conference, a premier Pharmaceutical Technology Conference, brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare industry.
  • Meet the decision makers, benchmark and learn from real-life use cases to drive organizational change and to understand the new cutting-edge technologies and practical solutions.
  • It gives us a great pleasure in welcoming you to our whole new pharmaceutical technology conference 7th Annual Digi-Tech Pharma & AI 2024.

OnePlus Watch 2 Hits the Market Today: Unveiling Price, Availability, and More

Retrieved on: 
Monday, March 4, 2024
Spotify, Android Oreo, Mobile, Skiing, Sale, Sport, Health, Fast Pair, Music, Google Maps, Running, Software, Architecture, Black Steel, Assistant, Map, HRV, MWC, Memory, OnePlus, Longevity, Google Wallet, Wear OS, Wear, VO2, IP68, Language, AOD, Swimming, Wi-Fi, RAM, Face, Stainless steel, IOS, L1, GMS, Tennis, Wrist, REM, Mobile phone

The OnePlus Watch 2 is packed with flagship features, including exceptional battery and charging performance for industry-leading reliability and longevity. It features OnePlus's self-developed Dual-Engine Architecture powered by two different flagship chipsets -- the Snapdragon W5 Gen 1 Wearable Platform, which runs demanding tasks, like running your favorite Google apps, and another BES2700 Efficiency Chipset, which runs RTOS and handles background activity and simple tasks. This optimized approach, enabled by the Wear OS hybrid interface seamlessly managing the transition between chips, means users will experience a smartwatch that effortlessly does it all while extending the time between charges.

Key Points: 
  • With its 2GB RAM and 32GB ROM configuration, the OnePlus Watch 2 also offers plenty of memory and storage to ensure the watch runs smoothly at all times.
  • Specifically for badminton, the OHealth app on the OnePlus Watch 2 can track data such as swing strength and speed.
  • With Fast Pair, you can quickly connect and set up your OnePlus Watch 2 with your OnePlus phone or other supported Android smartphone.
  • OnePlus Watch 2 only supports connecting with smartphones with Android 8.0 and above, which should also have a GMS version of 23.45.23 and above.

“Finish Your Story” in WWE® 2K24 Deluxe Edition and Forty Years of WrestleMania Edition Now Available Worldwide

Retrieved on: 
Tuesday, March 5, 2024
Technology, Electronic Games, Licensing (Sports), Sports, Wrestling, Entertainment, Mobile Entertainment, Software, Celebrity, Consumer Electronics, Giant, Rhea, Universe, Diamond, Online, Deluxe, Metacritic, Championship, Special edition, Superstar, DLC, QuickPlay, Creation, XP, Supercharger, Steam, History, WWE, Visual Concepts, TTWO, Xbox One, Microsoft Store, Gauntlet for the Gold, Bank, Referee (professional wrestling), Mattel, WWE Hall of Fame, Library, Standard, Multimedia, Immortal, Digital, Publishing, Forty Years, PC, Digital edition, Sony Interactive Entertainment, The Ultimate Warrior, PS4, WWE Superstars, PS5, Internet, Rivalry, Season ticket, CM Punk, Cody Rhodes, Take-Two Interactive, Cell, WarGames, PlayStation, Hell, TLC, GMS, Royal Rumble, Video game

* The Standard Edition and Standard Cross-Gen Digital Edition will be available on Friday, March 8, 2024.

Key Points: 
  • * The Standard Edition and Standard Cross-Gen Digital Edition will be available on Friday, March 8, 2024.
  • * The Standard Edition and Standard Cross-Gen Digital Edition will be available on Friday, March 8, 2024.
  • ;
    The Forty Years of WrestleMania Edition is available for $119.99 for PS4, PS5, Xbox Series X|S, Xbox One, and PC.
  • Deluxe Edition physical version available March 5 in select territories, and March 8 for the rest of the world.

GMS Completes the Acquisition of Kamco Supply Corporation

Retrieved on: 
Monday, March 4, 2024
Other Retail, Manufacturing, Construction & Property, Building Systems, Forest Products, Natural Resources, Other Manufacturing, Retail, Steel, Home Goods, Other Construction & Property, Acquisition, Growth, GMS, Hand

GMS Inc. (NYSE: GMS), a leading North American specialty building products distributor, today announced the successful completion of its previously disclosed acquisition of Kamco Supply Corporation (“Kamco”), a leading supplier of ceilings, wallboard, steel, lumber and other complementary construction products in the New York City metropolitan area.

Key Points: 
  • GMS Inc. (NYSE: GMS), a leading North American specialty building products distributor, today announced the successful completion of its previously disclosed acquisition of Kamco Supply Corporation (“Kamco”), a leading supplier of ceilings, wallboard, steel, lumber and other complementary construction products in the New York City metropolitan area.
  • “As we highlighted during our fiscal third quarter 2024 earnings report, we are pleased to complete this meaningful expansion into the New York City market and to welcome the Kamco team to GMS,” said John C. Turner, Jr., President and Chief Executive Officer of GMS.
  • “Aligned with the values of GMS, the Kamco team of respected professionals has a long tradition of providing outstanding customer service while offering a robust suite of products.
  • GMS funded the $321.5 million purchase price with cash on hand and available borrowings on its revolving credit facility.

GMS Reports Third Quarter Fiscal 2024 Results

Retrieved on: 
Thursday, February 29, 2024
Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Base rate, Share repurchase, Term loan, Growth, GMS, Calendar, Adjustment, Turner, Steel

GMS Inc. (NYSE: GMS), a leading North American specialty building products distributor, today reported financial results for the fiscal third quarter ended January 31, 2024.

Key Points: 
  • GMS Inc. (NYSE: GMS), a leading North American specialty building products distributor, today reported financial results for the fiscal third quarter ended January 31, 2024.
  • Single-family is also expected to show year-over-year growth for the fourth quarter as lower interest rates have resulted in higher activity levels.”
    Net sales for the third quarter of fiscal 2024 of $1.3 billion increased 1.9% as compared with the prior year quarter.
  • For the third quarter of fiscal 2024, cash provided by operating activities was $104.3 million, compared to $134.1 million in the prior year period.
  • GMS will host a conference call and webcast to discuss its results for the third quarter of fiscal 2024 ended January 31, 2024 and other information related to its business at 8:30 a.m. Eastern Time on Thursday, February 29, 2024.

GMS to Present at the Raymond James 45th Annual Institutional Investors Conference

Retrieved on: 
Tuesday, February 27, 2024
Other Manufacturing, Commercial Building & Real Estate, Textiles, Construction & Property, Steel, Manufacturing, Building Systems, Other Construction & Property, Residential Building & Real Estate, GMS, Conference

GMS Inc. (NYSE: GMS), a leading North American specialty building products distributor, is scheduled to present at the Raymond James 45th Annual Institutional Investors Conference on Tuesday, March 5, 2024 at 3:25 PM Eastern Time.

Key Points: 
  • GMS Inc. (NYSE: GMS), a leading North American specialty building products distributor, is scheduled to present at the Raymond James 45th Annual Institutional Investors Conference on Tuesday, March 5, 2024 at 3:25 PM Eastern Time.
  • The presentation will be webcast live on the Investors section of the Company’s website at www.gms.com and an archived replay will be available for approximately 180 days.